Can a woman in her late 50s with a childhood seizure triggered by prochlorperazine (Compazine) safely take bupropion (Wellbutrin)?

Can a Woman in Her Late 50s with a Childhood Seizure from Compazine Take Wellbutrin?

This patient can likely take bupropion (Wellbutrin) safely, as a single childhood seizure triggered by a medication (prochlorperazine) over 40 years ago does not constitute an active seizure disorder or ongoing seizure risk that would contraindicate bupropion use.

Key Clinical Reasoning

Understanding the Contraindication

Bupropion is contraindicated in patients with a current seizure disorder or conditions that increase seizure risk 1. The FDA label specifically lists contraindications including:

• Active seizure disorder
• Conditions increasing seizure risk (severe head injury, arteriovenous malformation, CNS tumor, severe stroke, anorexia/bulimia)
• Abrupt discontinuation of alcohol, benzodiazepines, barbiturates, or antiepileptic drugs 1

Why This Patient Likely Does NOT Meet Contraindication Criteria

The critical distinction here is between:

1. A provoked childhood seizure (medication-induced, single event, decades ago)
2. An active seizure disorder (recurrent unprovoked seizures or ongoing epilepsy)

A single provoked seizure from prochlorperazine in childhood does not establish a seizure disorder. Prochlorperazine (Compazine) is a phenothiazine antipsychotic that can lower seizure threshold and provoke seizures, particularly in susceptible individuals. This was a medication-induced event, not evidence of underlying epilepsy.

Seizure Risk with Bupropion in Context

The seizure risk with bupropion at recommended doses (≤450 mg/day) is approximately 0.1-0.4% 2, 3, which is comparable to other antidepressants 4, 5. A large prospective study of 3,341 patients found a seizure rate of 0.24% during the 8-week treatment phase and 0.40% overall 3.

Risk factors that DO increase seizure risk with bupropion include 1:

• Current seizure disorder or epilepsy
• History of head trauma with loss of consciousness
• CNS tumor or infection
• Eating disorders (anorexia/bulimia)
• Alcohol or benzodiazepine withdrawal
• Concomitant medications lowering seizure threshold
• Metabolic disorders (hypoglycemia, hyponatremia, severe hepatic impairment)

Clinical Approach

What You Need to Assess

Before prescribing bupropion, evaluate:

1. Has she had any seizures since childhood? If no seizures in 40+ years, this strongly suggests no underlying seizure disorder.

2. Was the childhood seizure truly isolated and medication-provoked? Confirm it occurred only during/after Compazine exposure and never recurred.

3. Does she have any current risk factors?

   • Active eating disorder
   • Alcohol abuse or recent withdrawal
   • Benzodiazepine use
   • Other medications that lower seizure threshold
   • Severe hepatic impairment
   • History of significant head trauma

4. Any family history of epilepsy? While not an absolute contraindication, this adds context.

Prescribing Strategy if Appropriate

If the patient has no current seizure risk factors:

• Start with lower dose: Begin at 150 mg once daily of extended-release formulation 1
• Titrate gradually: Increase to 300 mg daily after at least 4 days if tolerated
• Maximum dose: Do not exceed 450 mg/day (the dose-related seizure risk increases significantly above this) 1, 2
• Avoid high-fat meals: Can increase drug exposure 6
• Monitor closely: Educate patient about seizure warning signs

When to Avoid Bupropion

Choose alternative antidepressants if:

• Patient has had multiple seizures (even if childhood)
• Any unprovoked seizures in her history
• Current use of other seizure threshold-lowering medications
• Active eating disorder
• Significant alcohol use
• Patient or family anxiety about seizure risk is high

Safer alternatives for depression include 7:

• SSRIs (sertraline, escitalopram, fluoxetine)
• SNRIs (venlafaxine, duloxetine)
• Mirtazapine

Common Pitfalls to Avoid

1. Over-interpreting a single provoked childhood seizure as a permanent contraindication: This conflates a medication side effect with an underlying seizure disorder.

2. Failing to distinguish between provoked and unprovoked seizures: Provoked seizures (medication, fever, metabolic disturbance) have different implications than unprovoked seizures.

3. Not considering the time elapsed: A 40+ year seizure-free interval without antiepileptic medications strongly argues against active epilepsy.

4. Ignoring dose-dependent risk: The seizure risk with bupropion is highly dose-dependent; staying at ≤300 mg/day further reduces risk 2.

Bottom Line

A single childhood seizure provoked by Compazine does not constitute a contraindication to bupropion in a woman now in her late 50s, assuming no subsequent seizures and no current risk factors 1. The FDA contraindication targets active seizure disorders and conditions that currently increase seizure risk, not remote provoked events. However, if there is any uncertainty about her seizure history, or if she has other risk factors, choosing an alternative antidepressant (SSRI or SNRI) would be the more conservative approach 7.